Quazinone
Chemical compound
- None
- In general: ℞ (Prescription only)
- (3R)-6-Chloro-3-methyl-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one
- 70018-51-8
- 6603980
- 5036286
- D1Q7F6C2FP
- D05668
- DTXSID6045795
- Interactive image
- Clc1cccc3c1CN2/C(=N\C(=O)[C@H]2C)N3
Quazinone (Dozonone) is a cardiotonic and vasodilator drug which was developed and marketed in the 1980s for the treatment of heart disease.[1][2][3][4][5] It acts as a selective PDE3 inhibitor.[6][7] It is no longer available.[1]
See also
- Phosphodiesterase inhibitor
References
- ^ a b David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 978-0-412-46630-4.
- ^ Eigenmann R, Gerold M, Holck M (1984). "Cardiovascular profile of Ro 13-6438, a novel positive inotropic agent with vasodilating properties". Journal of Cardiovascular Pharmacology. 6 (3): 511–9. doi:10.1097/00005344-198405000-00021. PMID 6202980. S2CID 35907876.
- ^ Holck M, Thorens S, Muggli R, Eigenmann R (1984). "Studies on the mechanism of positive inotropic activity of Ro 13-6438, a structurally novel cardiotonic agent with vasodilating properties". Journal of Cardiovascular Pharmacology. 6 (3): 520–30. doi:10.1097/00005344-198405000-00022. PMID 6202981. S2CID 13286049.
- ^ Belz GG, Stern HC, Butzer R (1985). "Dose-response following single administrations of a new cardiac performance enhancer RO 13-6438 in normal volunteers". Journal of Cardiovascular Pharmacology. 7 (1): 86–90. doi:10.1097/00005344-198501000-00014. PMID 2580156. S2CID 27819870.
- ^ Daly PA, Chatterjee K, Viquerat CE, et al. (June 1985). "RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure". The American Journal of Cardiology. 55 (13 Pt 1): 1539–44. doi:10.1016/0002-9149(85)90969-5. PMID 4003296.
- ^ Osinski MT, Schrör K (August 2000). "Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis". Biochemical Pharmacology. 60 (3): 381–7. doi:10.1016/S0006-2952(00)00328-2. PMID 10856433.
- ^ Denis D, Riendeau D (February 1999). "Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes". European Journal of Pharmacology. 367 (2–3): 343–50. doi:10.1016/S0014-2999(98)00987-X. PMID 10079010.
External links
- Media related to Quazinone at Wikimedia Commons
- v
- t
- e
- BAY 60-7550
- Carbazeran
- EHNA
- Oxindole
- PDP
- Adibendan
- Amrinone (inamrinone)
- Anagrelide
- Benafentrine
- Bucladesine
- Carbazeran
- Cilostamide
- Cilostazol
- Enoximone
- Ensifentrine
- Imazodan
- KMUP-1
- Meribendan
- Milrinone
- Olprinone
- Parogrelil
- Pimobendan
- Pumafentrine
- Quazinone
- RPL-554
- Siguazodan
- Trequinsin
- Vesnarinone
- Zardaverine
- Apremilast
- Arofylline
- Atizoram
- Benafentrine
- Catramilast
- CC-1088
- CDP-840
- CGH-2466
- Cilomilast
- Cipamfylline
- Crisaborole
- Denbutylline
- Difamilast
- Drotaverine
- Ensifentrine
- Etazolate
- Filaminast
- Glaucine
- HT-0712
- ICI-63197
- Indimilast
- Irsogladine
- Lavamilast
- Lirimilast
- Lotamilast
- Luteolin
- Mesembrenone
- Mesembrine
- Mesopram
- Oglemilast
- Piclamilast
- Pumafentrine
- Revamilast
- Ro 20-1724
- Roflumilast
- Rolipram
- Ronomilast
- RPL-554
- RS-25344
- Tetomilast
- Tofimilast
- YM-976
- Zardaverine
- Acetildenafil
- Aildenafil
- Avanafil
- Beminafil
- Benzamidenafil
- Dasantafil
- Icariin
- Gisadenafil
- Homosildenafil
- Lodenafil
- Mirodenafil
- MY-5445
- Nitrosoprodenafil
- Norcarbodenafil
- SCH-51866
- Sildenafil
- Sulfoaildenafil
- T-0156
- Tadalafil
- Udenafil
- Vardenafil
- BAY 73-6691
- PF-04447943
- Paraxanthine
- Balipodect
- Mardepodect
- Papaverine
- TC-E 5005
- Tofisopam
BC11-38
- Diazepam
- Diprophylline
- DPCPX
- Furafylline
- Lisofylline
- MDL-12330A
- Moxaverine
- Oxagrelate
- Pentifylline
- Proxyphylline
- Quercetin
- Satigrel
- Tolafentrine
- Trapidil
See also: Receptor/signaling modulators